Gt Biopharma shares owned by Citadel Advisors
Quarter-by-quarter ownership of Gt Biopharma shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Gt Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Gt Biopharma held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Gt Biopharma by Citadel Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $15k | 58k | 0.26 |
2023-03-31 | $25k | 45k | 0.55 |
2022-06-30 | $246k | 82k | 2.99 |
2022-03-31 | $254k | 88k | 2.88 |
2021-12-31 | $243k | 80k | 3.06 |
2021-09-30 | $760k | 101k | 7.52 |
2021-06-30 | $7.9M | 510k | 15.46 |